Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Viraga Haridas

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Iscience|December 6, 2019
Cytoplasmic RNA Sensor Pathways and Nitazoxanide Broadly Inhibit Intracellular Mycobacterium tuberculosis GrowthShahin Ranjbar, Viraga Haridas, Aya Nambu, et al.
Journal of Virology|December 18, 2009
Targeted delivery of small interfering RNA to human dendritic cells to suppress dengue virus infection and associated proinflammatory cytokine productionSandesh Subramanya, Sang-Soo Kim, Sojan Abraham, et al.
AIDS (London, England)|December 9, 2014
TB-IRIS, T-cell activation, and remodeling of the T-cell compartment in highly immunosuppressed HIV-infected patients with TBViraga Haridas, Polidy Pean, Luke D Jasenosky, et al.
Iscience|August 13, 2019
The FDA-Approved Oral Drug Nitazoxanide Amplifies Host Antiviral Responses and Inhibits Ebola VirusLuke D Jasenosky, Cristhian Cadena, Chad E Mire, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 22, 2010
Enhanced induction of HIV-specific cytotoxic T lymphocytes by dendritic cell-targeted delivery of SOCS-1 siRNASandesh Subramanya, Myriam Armant, Janelle R Salkowitz, et al.
Cell|August 12, 2008
T cell-specific siRNA delivery suppresses HIV-1 infection in humanized micePriti Kumar, Hong-Seok Ban, Sang-Soo Kim, et al.
Cell|February 12, 2025
Neutrophil-derived vesicles control complement activation to facilitate inflammation resolutionAlan Y Hsu, Qingxiang Huang, Xiong Pi, et al.
Biorxiv : the Preprint Server for Biology|February 16, 2022
The oral drug nitazoxanide restricts SARS-CoV-2 infection and attenuates disease pathogenesis in Syrian hamstersLisa Miorin, Chad E Mire, Shahin Ranjbar, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Iscience|December 6, 2019
Cytoplasmic RNA Sensor Pathways and Nitazoxanide Broadly Inhibit Intracellular Mycobacterium tuberculosis GrowthShahin Ranjbar, Viraga Haridas, Aya Nambu, et al.
Journal of Virology|December 18, 2009
Targeted delivery of small interfering RNA to human dendritic cells to suppress dengue virus infection and associated proinflammatory cytokine productionSandesh Subramanya, Sang-Soo Kim, Sojan Abraham, et al.
AIDS (London, England)|December 9, 2014
TB-IRIS, T-cell activation, and remodeling of the T-cell compartment in highly immunosuppressed HIV-infected patients with TBViraga Haridas, Polidy Pean, Luke D Jasenosky, et al.
Iscience|August 13, 2019
The FDA-Approved Oral Drug Nitazoxanide Amplifies Host Antiviral Responses and Inhibits Ebola VirusLuke D Jasenosky, Cristhian Cadena, Chad E Mire, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 22, 2010
Enhanced induction of HIV-specific cytotoxic T lymphocytes by dendritic cell-targeted delivery of SOCS-1 siRNASandesh Subramanya, Myriam Armant, Janelle R Salkowitz, et al.
Cell|August 12, 2008
T cell-specific siRNA delivery suppresses HIV-1 infection in humanized micePriti Kumar, Hong-Seok Ban, Sang-Soo Kim, et al.
Cell|February 12, 2025
Neutrophil-derived vesicles control complement activation to facilitate inflammation resolutionAlan Y Hsu, Qingxiang Huang, Xiong Pi, et al.
Biorxiv : the Preprint Server for Biology|February 16, 2022
The oral drug nitazoxanide restricts SARS-CoV-2 infection and attenuates disease pathogenesis in Syrian hamstersLisa Miorin, Chad E Mire, Shahin Ranjbar, et al.
Pageof 2